First Report of Transradial Renal Denervation with the Dedicated Radiofrequency Iberis™ Catheter
Overview
Pharmacology
Affiliations
We describe the first use of transradial access renal denervation in a patient with resistant hypertension using a dedicated radiofrequency catheter (Iberis™; Terumo Medical Corporation, Tokyo, Japan). The system includes a generator and a 4 Fr single-use radiofrequency (RF) device which has to be introduced via a 6 Fr guiding catheter. Radiofrequency energy is delivered at the tip of the catheter. The system was CE approved in March 2013.
Lo H, Lee J, Lin Y Hypertens Res. 2024; 47(3):760-766.
PMID: 38177288 DOI: 10.1038/s41440-023-01540-3.
Wang T, Lee Y, Chang S, Tung Y, Yeh C, Lin Y Acta Cardiol Sin. 2019; 35(3):199-230.
PMID: 31249454 PMC: 6533581. DOI: 10.6515/ACS.201905_35(3).20190415A.
Renal Sympathetic Denervation in Patients with Resistant Hypertension: A Feasibility Study.
Kario K, Rumoroso J, Okawara Y, de Prado A, Garcia Fernandez E, Kagitani H Pulse (Basel). 2019; 6(3-4):137-143.
PMID: 31049313 PMC: 6489090. DOI: 10.1159/000490620.
Renal Sympathetic Denervation - A Review of Applications in Current Practice.
Kapil V, Jain A, Lobo M Interv Cardiol. 2018; 9(1):54-61.
PMID: 29588780 PMC: 5808654. DOI: 10.15420/icr.2011.9.1.54.
Sakaoka A, Takami A, Onimura Y, Hagiwara H, Terao H, Kumagai F Catheter Cardiovasc Interv. 2017; 90(4):631-638.
PMID: 28639746 PMC: 6585757. DOI: 10.1002/ccd.27158.